
NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
Robins et al. v. Lemme Inc.
25-cv-1938, S.D.N.Y.
(March 2025)
Lemme GLP-1 Daily Capsules
Misleadingly marketing that products will reduce hunger and cause weight loss when clinical evidence does not support such claims
Misleadingly marketing that the ingredients in the products have been clinically tested when the combination of ingredients in the supplement has not been clinically tested
Pending
If you’ve been misled by an ad, regulators want to hear from you. We do too.
It’s easier to rack up hidden fees than it is to cancel.
The only thing more “ridiculous” than the touted benefits is the cancellation process.
Under a proposed bill, theaters could be fined for making moviegoers guess.
Money-back guarantee comes up woefully short of advertised percentage.